Suchergebnisse - "Strouse, Christopher"

PubPharm (36)

1

Transplant versus no transplant in myelodysplastic syndrome and acute myeloid leukemia with TP53 mutation; a referral center experience

enthalten in: European journal of haematology | 2024

von Poonsombudlert, K. | Mott, S. | Miller, B. | +8

2

A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation

enthalten in: Cancers | 2024

von Guo, W. | Strouse, C. | Mery, D. | +18

3

Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma : A Real-World Experience

enthalten in: Transplantation and cellular therapy | 2024

von Dima, D. | Davis, J. | Ahmed, N. | +16

4

Improving Rural Clinical Trial Enrollment : Recommendations From the Rural Health Working Group of the Alliance Clinical Trials Network

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Stout, N. | Nikcevich, D. | Henderson, T. | +44

5

Transplant conditioning with bortezomib, thalidomide, and melphalan and intensive 2 year post-transplant therapy for multiple myeloma in older patients

enthalten in: Bone marrow transplantation | 2024

von Strouse, C. | Mott, S. | Smith, B. | +5

6

Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma

enthalten in: Haematologica | 2023

von Maurer, M. | Casulo, C. | Larson, M. | +20

7

Acute auto-aggression syndrome following autologous hematopoietic stem cell transplant and lenalidomide for multiple myeloma

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2023

von Struble, E. | Ginn, M. | Strouse, C.

8

Impact of Public Reporting of Center-Specific Survival Analysis Scores on Patient Volumes at Hematopoietic Cell Transplant Centers

enthalten in: Transplantation and cellular therapy | 2023

von Sharma, A. | Logan, B. | Estrada-Merly, N. | +13

CommentIn: Transplant Cell Ther. 2023 Aug;29(8):482-483. - PMID 37517846

9

Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma

enthalten in: Cancer | 2023

von Bumma, N. | Dhakal, B. | Fraser, R. | +23

10

Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma : a CIBMTR analysis

enthalten in: Blood advances | 2023

von Ragon, B. | Shah, M. | D'Souza, A. | +39

CommentIn: Blood Adv. 2023 Jun 27;7(12):2731-2732. - PMID 37318936